Sonova reports solid full-year growth, shares steady on SIX Swiss Exchange
28.06.2026 - 12:10:03 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 12:09.
Sonova Holding AG (CH0012549785) published its full-year 2024/25 results with higher sales and earnings and confirmed a planned CEO transition, according to an overview of the announcement from Stäfa, Switzerland. The stock trades on SIX Swiss Exchange, where the shares have shown a moderate performance in recent sessions.
What Sonova reported in 2024/25
For the fiscal year 2024/25, Sonova reported full-year sales of around CHF 3.87 billion, representing 7.6 percent growth in local currencies and 6.6 percent in Swiss francs compared with the prior year. This expansion came across all four business segments, pointing to a broadly supported increase in demand for hearing-care solutions.
The company also highlighted improved profitability, building on efficiency measures and a product mix shift toward higher-value devices and services, according to summaries of the results. In parallel with the financial numbers, Sonova confirmed a CEO handover, with a new chief executive set to take over leadership to drive the next phase of the group’s strategy.
Analyst view and valuation markers
On the secondary OTC market, the Sonova ADR with the ticker SONVY shows a market capitalization close to 14.3 billion US dollars at a recent price around 47.93 dollars as of June 26, 2026. The security carries a dividend yield of about 1.46 percent, underlining Sonova’s profile as a dividend-paying stock in the global healthcare segment.
MarketBeat data lists a consensus recommendation of "Moderate Buy" on Sonova, indicating that most covering analysts remain constructive on the stock while acknowledging valuation and competitive factors. The 52-week range on the ADR extends from roughly 42.26 dollars to 61.10 dollars, providing a frame for the recent trading bandwidth around the company’s results and leadership change.
All news and data on the Sonova shares
Further articles and price information on Sonova Holding AG are available in the dedicated topic section and on the company’s Investor Relations page.
The products behind the Sonova stock
Sonova’s core business is hearing care, spanning hearing instruments under brands such as Phonak and Unitron, cochlear implants, and related audiological services provided through its retail networks. The group generates revenue from both the sale of advanced hearing devices and long-term fitting, maintenance and counseling for patients via audiologists and hearing centers.
Where the Sonova shares trade today
Sonova Holding AG shares (CH0012549785) trade on SIX Swiss Exchange; based on recent indicative data, the stock is around the equivalent of 47.93 US dollars per ADR as of 2026-06-26, 15:58 Eastern Time, corresponding to a market capitalization of approximately 14.3 billion dollars.
Key data on the Sonova shares
- Company: Sonova Holding AG
- ISIN: CH0012549785
- WKN: 125497
- Ticker: SONN on SIX, SONVY as ADR
- Trading venue: SIX Swiss Exchange (primary listing), OTCMKTS (ADR)
- Price (as of 2026-06-26, 15:58): 47.93 USD (ADR)
- Market cap: 14.29 billion USD (as of 2026-06-26)
- Sector / industry: Healthcare, Medical Equipment, Hearing Care
- Index membership: SMI / SPI (Switzerland)
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.
